Deletion of CARD9 downregulates p38 MAPK activity and reduces the levels of these inflammatory cytokines and macrophage infiltration, and improves cardiac hypertrophy, fibrosis, and dysfunction 11, 12, 44, 45. Here, CARD9 is linked to cardiac hypertrophy.